The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
The hypertriglyceridemic waist (HW) phenotype is strongly associated with type 2 diabetes; however, to date, no study has assessed the predictive power of phenotypes based on individual anthropometric measurements and triglyceride (TG) levels. The aims of the present study were to assess the association between the HW phenotype and type 2 diabetes in Korean adults and to evaluate the predictive power...
METABO is a diabetes monitoring and management system which aims at recording and interpreting patient's context, as well as, at providing decision support to both the patient and the doctor. The METABO system consists of (a) a Patient's Mobile Device (PMD), (b) different types of unobtrusive biosensors, (c) a Central Subsystem (CS) located remotely at the hospital and (d) the Control Panel (CP) from...
Fast developing information and communication technologies based on Internet and mobile networks have changed our daily lives in a very positive way. Take for an example Diyahat.net, an important development in health information technologies, which enables diabetics to collect, store and manage data about blood glucose measurements, medication and diet lists using mobile technologies as well as Internet...
In this work, a simulation study of run-to-run control is developed for multiple-daily injections (MDI) therapy. Insulin lispro and insulin glargine are employed in the protocol which uses pre- and post-prandial glucose measurements. The key information during the synthesis of the control algorithm is the patient insulin sensitivity that is calculated considering that there is no previous information...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.